Clinical Psychedelic Lab Project #4: The formation and structure of psychedelic-catalysed insights and their role in therapeutic change

Building on ongoing work in our lab investigating psychedelic-catalysed insight (PCI), this PhD project will focus on identifying the contextual and therapeutic factors that predict the emergence of meaningful insights during psychedelic-assisted therapy. The project aims to develop a detailed cartography of PCI and explore how these insights contribute to specific life changes and their impact on treatment outcomes for specific mental health conditions. This project seeks to further elucidate the role of adaptive and maladaptive insight in psychedelic treatments and explore the risk of false insight, towards optimising clinical methods. The Clinical Psychedelic Lab at Monash University is Australia's first psychedelic lab, leading a rigorous program of research in psychedelic medicine that seeks to evaluate therapeutic effects, innovate on treatment design, mitigate known risks, explore potential drawbacks, and understand therapeutic mechanisms. We're a warm and ambitious group of researchers and clinicians working to develop and test best practice across multiple psychedelic therapies and for several different mental health conditions. There are various active and upcoming projects within the group, and this project is listed as an example among many options. To see other possible project ideas, visit this page: https://www.monash.edu/medicine/scs/clinical-psychedelic-lab/support-us To find out more about the lab, go to www.monash.edu/psychedelics